Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U11 small nuclear 6, pseudogene (RNU11-6P) is a non-coding RNA classified specifically as a pseudogene in the human genome[7]. It is annotated by the HGNC (46946), NCBI Gene (106480544), and Ensembl (ENSG00000212429) as a pseudogene related to the U11 spliceosomal RNA gene family, which play a role in the minor spliceosome. However, as a pseudogene, RNU11-6P is generally considered non-functional (it does not encode a functional RNA or protein), and there is no evidence that it is expressed or has an active biological function. It is not regarded as a therapeutic target, has no associated drugs, roles in disease, or biomarker applications. Due to its status as an unprocessed pseudogene rather than an active gene or protein, this entry is likely included in genomic resources for completeness but is not biomedically actionable or relevant as a drug target[7]. Notes on correctness and biomedical targeting: - *RNU11-6P is a pseudogene*, meaning it is an inactive copy of a functional gene (here, related to U11 snRNA, which is involved in mRNA splicing[1][5][7]). Pseudogenes like RNU11-6P do not produce functional molecules and are not considered actionable therapeutic targets. - There are various functional copies in the U11 snRNA gene family (such as RNU11), but RNU11-6P itself is not functional[7]. - No diseases, pathways, or pharmacological interactions are described for pseudogenes like RNU11-6P, and there are no established functions, disease associations, or therapeutic applications in the literature[7]. Summary: RNU11-6P is a non-functional genomic pseudogene related to the U11 snRNA gene and is not considered a therapeutic target or relevant for drug development or disease biomarker research[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U11 small nuclear 6, pseudogene (RNU11-6P).